ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

New drugs harness the body's own cancer-fighting abilities

Immunotherapy drugs boast greater efficacy with fewer side effects

Merck's research facility in the U.S. state of Massachusetts

OSAKA -- A new class of drugs known as immune checkpoint inhibitors could drastically change the way cancer is treated. Rather than attack cancer cells directly, like conventional drugs, these new treatments work by unleashing the cancer-killing ability of the body's immune system.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more